tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Solvonis Therapeutics plc (GB:SVNS)
LSE:SVNS
UK Market
SVNS
Solvonis Therapeutics
RESEARCH TOOLSreports

Solvonis Therapeutics (SVNS) Stock News & Sentiment

Compare
12 Followers
Solvonis Wins U.S. Patent Boost for Novel PTSD Drug Programme
Premium
Company Announcements
Solvonis Wins U.S. Patent Boost for Novel PTSD Drug Programme
7d ago
Solvonis Therapeutics Maps Out Catalyst-Rich 2026 as CNS Pipeline Gains Momentum
Premium
Company Announcements
Solvonis Therapeutics Maps Out Catalyst-Rich 2026 as CNS Pipeline Gains Momentum
23d ago
Solvonis’ SVN-015 Accepted into NIDA Program for Addiction Treatment
Premium
Company Announcements
Solvonis’ SVN-015 Accepted into NIDA Program for Addiction Treatment
1M ago
Solvonis Therapeutics Updates Share Capital Details
Premium
Company Announcements
Solvonis Therapeutics Updates Share Capital Details
3M ago
Solvonis Therapeutics Streamlines Operations and Enhances R&D Focus
Premium
Company Announcements
Solvonis Therapeutics Streamlines Operations and Enhances R&D Focus
3M ago
Solvonis Therapeutics Appoints Paul Carter as Non-Executive Director
Premium
Company Announcements
Solvonis Therapeutics Appoints Paul Carter as Non-Executive Director
3M ago
Solvonis Therapeutics Raises £1.25 Million to Boost CNS Disorder Programs
Premium
Company Announcements
Solvonis Therapeutics Raises £1.25 Million to Boost CNS Disorder Programs
3M ago
More GB:SVNS News >

SVNS News on the Web

Solvonis Therapeutics adds patent protection for its post-traumatic stress disorder programme
Proactive Investors
Neutral
2025 a ‘transformative’ year as Solvonis lines up key milestones
Proactive Investors
Neutral
Solvonis jumps after US programme backs early testing of addiction drug
Proactive Investors
Neutral
Solvonis compound enters US addiction research programme backed by NIDA
Proactive Investors
Neutral
Solvonis restructures to streamline operations and focus on drug development
Proactive Investors
Bullish
Solvonis adds biopharma leader Paul Carter to board
Proactive Investors
Neutral
Solvonis raises £1.25m to boost CNS drug pipeline - ICYMI
Proactive Investors
Neutral
Solvonis raises £1.25 million to expand CNS drug pipeline
Proactive Investors
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:SVNS’s Media Buzz Sentiment?
Currently, no data Available
What is GB:SVNS’s weekly average amount of articles?
Currently, no data Available
What is GB:SVNS’s News Sentiment?
Currently, no data Available
Industrials Stocks that are Trending in the News
DALDelta Air Lines
AIRAAR
SNCYSun Country Airlines Holdings
LMTLockheed Martin
NOCNorthrop Grumman
Showing the stocks with the most bullish news sentiment over the past week